Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Obstet Gynecol ; 97(6): 954-60, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11384702

ABSTRACT

OBJECTIVE: To evaluate the effect of antenatal corticosteroids on mortality, morbidity, and disability or handicap rate in early preterm, growth-restricted infants. METHODS: This case-control study in two tertiary care centers included all live-born singleton infants with growth-restriction due to placental insufficiency, who were delivered by cesarean because of cardiotocographic signs of fetal distress before the beginning of labor at a gestational age of 26-32 weeks during the years 1984-1991. Infants who had been treated antenatally with corticosteroids more than 24 hours and less than 7 days before birth were matched by birth weight, sex, and year of birth with infants whose mothers had been admitted more than 24 hours before delivery but were not treated antenatally with steroids. The main outcome measure was survival without disability or handicap at 2 years corrected age. A sample of 60 case-control pairs would give 81% power to demonstrate 50% increase of this outcome [odds ratio (OR) 3.0] by corticosteroid treatment. Behavior and physical growth were evaluated at school age by questionnaire. RESULTS: The study group and control group consisted of 62 infants each. Survival without disability or handicap at 2 years' corrected age was more frequent in the corticosteroid group [OR 3.2, confidence interval (CI) 1.1, 11.2]. In the long-term follow-up at school age there was a statistically significant negative effect on physical growth (OR 5.1, CI 1.4, 23.8), but no differences in behavior were detected. CONCLUSION: Benefits from antenatal corticosteroids for early preterm, growth-restricted infants appear to outweigh possible adverse effects.


Subject(s)
Adrenal Cortex Hormones/administration & dosage , Cause of Death , Fetal Distress/drug therapy , Fetal Growth Retardation/epidemiology , Infant, Premature, Diseases/drug therapy , Infant, Premature, Diseases/mortality , Adult , Case-Control Studies , Cesarean Section , Child, Preschool , Cohort Studies , Confidence Intervals , Disease-Free Survival , Female , Fetal Growth Retardation/diagnosis , Follow-Up Studies , Growth/drug effects , Humans , Infant , Infant, Newborn , Netherlands/epidemiology , Odds Ratio , Pregnancy , Prenatal Care/methods , Reference Values , Survival Rate
2.
Eur J Pediatr ; 159(6): 450-2, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10867852

ABSTRACT

UNLABELLED: Since the mid-1980s, an increase in incidence of invasive disease caused by group A streptococci has been noted amongst adults and children; however, neonatal disease is still rare. Between 1979 and 1998, seven neonates with severe group A streptococcal disease were admitted to our neonatal intensive care unit. The clinical presentation, treatment and outcome are described. In three cases of early-onset disease vertical transmission was documented. CONCLUSION: Because the incidence of group A streptococcal disease in the general population seems to have increased over the last two decades, we should be aware of the possibility and particularly the severity of group A streptococcal disease in the neonatal period.


Subject(s)
Streptococcal Infections/diagnosis , Streptococcal Infections/therapy , Streptococcus pyogenes , Female , Humans , Infant, Newborn , Male , Severity of Illness Index
3.
Eur J Obstet Gynecol Reprod Biol ; 86(1): 43-9, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10471141

ABSTRACT

OBJECTIVE: To describe school performance and behaviour of extremely preterm, growth-retarded infants. DESIGN: Cohort study at two tertiary care centres. Included were all surviving, singleton infants (N= 127) with fetal growth retardation due to placental insufficiency. All were delivered by caesarean section because of signs of fetal distress before the beginning of labour at a gestational age of 26 to 32 weeks during the years 1984-1989. Main outcome measures were special education, mainstream education below the appropriate age level and behaviour according to attention-deficit hyperactivity criteria at school age (4 1/2-10 1/2 yrs). The children were divided into two subgroups according to age at follow-up (> or =7 1/2 and <7 1/2 yr). A logistic regression analysis was performed with special school or repeating a grade and behavioural disturbance as dependent variables and gestational age, birth weight, sex of the infant, neonatal complications (intra cerebral haemorrhage, respiratory distress syndrome, bronchopulmonary dysplasia or sepsis), age category at follow-up and sociodemographic factors as independent variables. RESULTS: 114 (90%) had a complete follow-up. Special education was found in 14% of the assessed children. More children in the older age group than in the younger age group were placed in special school (20% versus 10%). Behavioural problems were scored in 39% of the assessed children attending mainstream education. Special education was related to neonatal complications (bronchopulmonary dysplasia), behavioural problems to the absence of either parent. CONCLUSION: This specific group of growth-retarded children is at serious disadvantage for adequate performance in school, although the incidence of special education and behavioural problems was comparable to other preterm infants. Both special education and behavioural problems were not related to obstetric variables as gestational age and/or birth weight.


Subject(s)
Child Behavior , Infant, Premature , Infant, Small for Gestational Age , Learning Disabilities/epidemiology , Child , Follow-Up Studies , Gestational Age , Humans , Infant, Newborn , Logistic Models , Risk Factors
4.
Br J Obstet Gynaecol ; 106(5): 486-91, 1999 May.
Article in English | MEDLINE | ID: mdl-10430200

ABSTRACT

OBJECTIVE: To determine the optimum mode of delivery of the early preterm fetus in breech presentation. DESIGN: Retrospective comparison of two cohorts of preterm breech fetus. SETTING: Two tertiary care centres: at one centre the preferred management for preterm breech presentation was vaginal delivery; at the other centre, the preferred method was caesarean section. POPULATION: All singleton infants delivered after breech presentation from 1984 through 1989, at a gestational age of 26 to 31 weeks. Those with lethal congenital abnormalities, placenta praevia, placental abruption, fetal death or fetal distress before the onset of labour were excluded. MAIN OUTCOME MEASURES: Survival without disability or handicap documented at two years corrected age. The influence of a number of relevant variables on this outcome was assessed by logistic regression analysis. RESULTS: There was no difference in survival without disability or handicap between the centres (odds ratio 1.5, 95% CI 0.6-3.9 vaginal delivery compared with caesarean section). Survival without disability or handicap was positively influenced by increasing birthweight and corticosteroids > 24 h before birth, and negatively influenced by footling presentation. CONCLUSION: A policy of caesarean section for early preterm (26-31 weeks) breech delivery is not associated with increased survival without disability or handicap.


Subject(s)
Breech Presentation , Delivery, Obstetric/methods , Obstetric Labor, Premature , Adult , Cesarean Section , Cohort Studies , Female , Follow-Up Studies , Gestational Age , Humans , Infant, Newborn , Pregnancy , Pregnancy Outcome , Retrospective Studies
5.
Arch Dis Child Fetal Neonatal Ed ; 77(2): F95-9, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9377153

ABSTRACT

AIM: To describe the long term outcome of extremely preterm growth retarded infants in relation to obstetric management and various perinatal events. METHODS: A cohort study was undertaken in two tertiary care centres with different obstetric management. All infants with fetal growth retardation due to placental insufficiency and resulting in fetal distress at 26 to 32 weeks of gestation, were included for the years 1984-89. Main outcome measures were impairment, disability, or handicap at 2 years corrected age and at school age (4 1/2 to 10 1/2 years). RESULTS: One hundred and twenty five (98%) were followed up until 2 years corrected age in the outpatient department; 114 (90%) were assessed at school age. Impairments were found in 37% and disabilities or handicaps in 9% of the assessed infants, with no difference between centres. All disabled or handicapped children had already been identified by 2 years corrected age. CONCLUSIONS: Disability or handicap were related to neonatal complications (intracerebral haemorrhage or bronchopulmonary dysplasia) and not to obstetric variables, thus making antenatal prediction impossible. The incidence of disability or handicap in these growth retarded infants was comparable with that of other preterm infants.


Subject(s)
Cesarean Section , Fetal Growth Retardation , Infant, Premature , Infant, Very Low Birth Weight , Bronchopulmonary Dysplasia/complications , Cerebral Hemorrhage/complications , Child, Preschool , Developmental Disabilities/etiology , Female , Follow-Up Studies , Humans , Infant, Newborn , Pregnancy , Prospective Studies , Treatment Outcome
6.
Eur J Obstet Gynecol Reprod Biol ; 70(1): 61-8, 1996 Dec.
Article in English | MEDLINE | ID: mdl-9031922

ABSTRACT

OBJECTIVE: To compare perinatal mortality and short-term morbidity in extremely preterm infants with fetal distress due to placental insufficiency in two centers with different management attitude. DESIGN: Retrospective cohort study in two university hospitals of all infants with fetal growth retardation due to placental insufficiency resulting in signs of fetal distress at 26 through 31 weeks gestational age, during the years 1984 through 1989. Center A followed a conservative management: in some cases the risk of major handicaps or mortality was estimated so high, based on antenatally estimated fetal weight and gestational age, that the decision was taken to abstain from treatment. In all other cases cesarean section took place, but only if fetal distress was obvious. Center B used a more active management: cesarean section was performed in all cases, sometimes with only minor changes in fetal heart rate variability. RESULTS: Overall survival differed significantly: 55% (center A) versus 72% (center B), largely due to antenatal mortality in center A. Discharge survival rate of liveborn infants was 81% in center A and 72% in center B. More than half of the postnatal mortality was attributed to respiratory causes in both centres. An active management showed a tendency to a higher incidence of short-term morbidity. CONCLUSION: Selection by antenatal prediction of postnatal mortality using estimated fetal weight fails. Even in the group with the lowest birthweight postnatal mortality did not surpass 50%. Early intervention may be associated with higher short-term morbidity. Long-term follow-up of these children is needed to discriminate between both policies with regard to further development of surviving infants.


Subject(s)
Fetal Distress/etiology , Fetal Distress/therapy , Fetal Growth Retardation/etiology , Gestational Age , Placental Insufficiency/complications , Bronchopulmonary Dysplasia/epidemiology , Cesarean Section , Cohort Studies , Female , Fetal Distress/mortality , Fetal Growth Retardation/therapy , Hospitals, University , Humans , Infant, Newborn , Infant, Premature , Male , Pregnancy , Respiration, Artificial , Respiratory Distress Syndrome, Newborn/epidemiology , Retrospective Studies , Survival Rate
7.
Br J Haematol ; 70(4): 465-9, 1988 Dec.
Article in English | MEDLINE | ID: mdl-3219297

ABSTRACT

IgG antibodies against blood group antigens A or B (anti-A/B) are able to sensitize erythrocytes for destruction in an antibody-dependent cell-mediated (ADCC) assay with monocytes as effector cells. The activity of maternal IgG anti-A/B in this test was compared with clinical signs of haemolytic disease of the newborn (HDN). When the ADCC was negative (less than 10% of the sensitized cells lysed), signs of increased red-cell destruction in the children were never observed. In three cases with a strongly positive ADCC (greater than 45% lysis), the children were severely affected and needed more than one exchange transfusion. In the cases with greater than 10% but less than 45% lysis in the ADCC, there was no clear correlation between the result of the ADCC and the degree of lysis in the newborn infants. In these cases, the degree of lysis of the red cells of the infant was shown to be strongly influenced by the number of A/B antigens per red cell. There was a direct correlation between the degree of lysis in the ADCC and the titre of IgG3 anti-A/B in the sera. There was comparable activity of maternal IgG anti-A/B in the ADCC test in the 32nd week of pregnancy and at the moment of delivery.


Subject(s)
ABO Blood-Group System/immunology , Erythroblastosis, Fetal/immunology , Fetal Blood/immunology , Immunoglobulin G/analysis , Antibody-Dependent Cell Cytotoxicity , Coombs Test , Enzyme-Linked Immunosorbent Assay , Female , Hemolysis , Humans , Infant, Newborn , Pregnancy
8.
Lancet ; 2(8612): 641-4, 1988 Sep 17.
Article in English | MEDLINE | ID: mdl-2901516

ABSTRACT

In 80 newborn infants ABO-incompatible with their mothers, the lysis-inducing effect of the maternal IgG anti-A or anti-B antibodies in an antibody-dependent cell-mediated cytotoxicity (ADCC) assay and the antigen density of A or B antigens on the red cells of the children were measured. On the basis of the results, the children were divided into two groups--24 children in whom increased haemolysis was to be expected, and 56 children in whom it was not. Signs of haemolysis and serological features of ABO haemolytic disease of the newborn (ABO-HDN) were compared in these two groups and a control group of 120 ABO-compatible infants. The effect of the maternal antibodies in the ADCC assay, the titres of maternal IgG anti-A or anti-B antibodies, the results of the direct antiglobulin test on the red cells in the cord blood, and the titre of IgG anti-A or anti-B antibodies in the serum of the infants were compared for their ability to predict the severity of ABO-HDN. This was also done for the combination of the ADCC assay results plus the A or B antigen density and the direct antiglobulin test plus the titre of maternal IgG anti-A or anti-B antibodies. The ADCC assay with maternal serum was the most sensitive assay to predict ABO-HDN, and the combination of the ADCC assay with A or B antigen density determination the most specific test.


Subject(s)
ABO Blood-Group System/immunology , Erythroblastosis, Fetal/immunology , Antibody-Dependent Cell Cytotoxicity , Bilirubin/blood , Erythroblastosis, Fetal/blood , Erythroblastosis, Fetal/complications , Female , Fetal Blood/immunology , Hemoglobins/metabolism , Humans , Hyperbilirubinemia/etiology , Hyperbilirubinemia/therapy , Immunoglobulin G/immunology , Infant, Newborn , Maternal-Fetal Exchange , Predictive Value of Tests , Pregnancy
10.
J Hosp Infect ; 3(3): 275-84, 1982 Sep.
Article in English | MEDLINE | ID: mdl-6183320

ABSTRACT

An analysis was made of all cases of infection among 181 neonates admitted to the neonatal intensive care unit (NICU) during one year. Twenty-four per cent had an infection on admission; their infections correlated with prolonged ruptured membranes and the degree and site of colonization. The predominant organisms found in perinatal infections were Staphylococcus aureus, Group B streptococci and Escherichia coli. Thirty per cent acquired a hospital infection. This correlated with the length of the period of instrumentation. The majority of the hospital-acquired infections was caused by Gram-positive cocci (micrococci, Staph. saprophyticus, Staph. aureus, forming 65 per cent of the total), E. coli and Pseudomonas aeruginosa. Most hospital infections were nosocomial and not auto-infection. The outcome of the neonates with hospital infection was good, except for those with pseudomonas infection. Acquisition of hospital infection prolonged the period of hospitalization up to twice that required for neonates without infection.


Subject(s)
Bacterial Infections/epidemiology , Infant, Newborn, Diseases/epidemiology , Intensive Care Units, Neonatal , Bacteria/isolation & purification , Bacterial Infections/microbiology , Bacteriological Techniques , Cross Infection/epidemiology , Female , Fetal Membranes, Premature Rupture/complications , Gestational Age , Humans , Infant, Newborn , Male , Netherlands , Pregnancy
12.
J Pediatr ; 96(1): 88-93, 1980 Jan.
Article in English | MEDLINE | ID: mdl-7350322

ABSTRACT

In order to elucidate some of the unexplained phenomena in prolonged patency of the ductus arteriosus in preterm infants, the histology of the ductus was studied in 27 cases. Some of the infants had been treated with indomethacin. Four morphologic maturation stages are distinguished. There was no strict relation between gestational age or birth weight and histologic maturation. Therefore, one cannot predict whether a ductus is likely to be mature at the time of birth. In all infants with clinically diagnosed prolonged patency of the ductus beyond the first week, the immature maturation stage or the permanent patent type was observed. In both stages, reopening after initial closure with indomethacin occurred.


Subject(s)
Ductus Arteriosus, Patent/pathology , Ductus Arteriosus, Patent/drug therapy , Fetus , Gestational Age , Humans , Indomethacin/therapeutic use , Infant, Newborn , Infant, Premature
14.
Eur J Cardiol ; 5(4): 321-5, 1977 Jun.
Article in English | MEDLINE | ID: mdl-891577

ABSTRACT

Prostaglandin type E1 has been administered on 4 different occasions in a newborn with a ductus-dependent complex congenital cyanotic heart disease. Dramatic improvement of the arterial oxygen concentration followed each prostaglandin infusion. Increased pulmonary circulation and widening of the ductus arteriosus were seen on angiographic examination. Transient flushing of the skin and mild pyrexia were the only complications noted. It is advised that prostaglandin type E1 be used in ductus-dependent heart diseases as an emergency therapy when indicated.


Subject(s)
Ductus Arteriosus, Patent/complications , Hypoxia/drug therapy , Prostaglandins E/therapeutic use , Emergencies , Humans , Hypoxia/etiology , Infant, Newborn , Male , Oxygen/blood , Pulmonary Circulation/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...